knowledge -WSS

knowledge

author：hotspot 2025-10-06 19:10:06 - browse：66231

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Testing for cancer recurrence creates a new limbo for patients

WSS

Readout Newsletter: What happened with Sarepta's Duchenne data

Trump indictment: Who are the 'co

Maker of FluMist seeks to allow at

The high personal cost of affirmative action for Black doctors

5 important ways Henrietta Lacks changed medical science

Meta's Zuckerberg and Chan on track to put $50 billion into science

focus

knowledge

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: XBI biotech index, Akero Therapeutics

Hollywood unions extend contract negotiations for actors

National panel will explore requiring free Covid tests

Malaria cases in Florida and Texas: Here’s what you need to know

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

In Memoriam: Notable people who died in 2023

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

What does generative AI mean for health care? We asked experts

NIH launches clinical trials and new research office for long Covid

focus

Sage hopes for a blockbuster in antidepressant now before FDA

The high personal cost of affirmative action for Black doctors

Paying for Covid pills will soon shift to insurers

Pence says 'crackpot lawyers' told Trump what he wanted to hear

EQRx, failed developer of low

Wildfire pollution widens asthma inequities on Long Island

knowledge

hotspot

explore

hotspot